These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34442713)

  • 1. Bioactive Compounds in Food as a Current Therapeutic Approach to Maintain a Healthy Intestinal Epithelium.
    Salinas E; Reyes-Pavón D; Cortes-Perez NG; Torres-Maravilla E; Bitzer-Quintero OK; Langella P; Bermúdez-Humarán LG
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of functional food components on gut health.
    Wan MLY; Ling KH; El-Nezami H; Wang MF
    Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability--a new target for disease prevention and therapy.
    Bischoff SC; Barbara G; Buurman W; Ockhuizen T; Schulzke JD; Serino M; Tilg H; Watson A; Wells JM
    BMC Gastroenterol; 2014 Nov; 14():189. PubMed ID: 25407511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions.
    Gourbeyre P; Denery S; Bodinier M
    J Leukoc Biol; 2011 May; 89(5):685-95. PubMed ID: 21233408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
    Ooi SL; Correa D; Pak SC
    Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier.
    Barbara G; Barbaro MR; Fuschi D; Palombo M; Falangone F; Cremon C; Marasco G; Stanghellini V
    Front Nutr; 2021; 8():718356. PubMed ID: 34589512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Chronic Constipation: A Review and Update.
    Ohkusa T; Koido S; Nishikawa Y; Sato N
    Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
    [No Abstract]   [Full Text] [Related]  

  • 15. Rebuilding the Gut Microbiota Ecosystem.
    Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.